New biological solutions for hemodialysis access

Journal of Vascular Access

Volumn 12, Issue 3, 2011, Pages 185-192

  Peck, Marissa K ^a   Dusserre, Nathalie ^a   Zagalski, Krzysztof ^b   Garrido, Sergio A ^c   Wystrychowski, Wojciech ^b   Glickman, Marc H ^d   Chronoss, Nicolas A F ^e   Cierpka, Lech ^b   L'Heureux, Nicolas ^a,e   McAllister, Todd N ^a,e  

^a Cytograft Tissue Engineering   (United States)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c FLENI   (Argentina)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e Saint JJoseph's Translational Research Institute   (United States)

Author keywords

Hemodialysis access; Self assembly; Small diameter; Tissue engineering; Vascular grafts

Indexed keywords

DACRON; POLITEF; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; TISSUE SCAFFOLD;

ALLOGRAFT; BLOOD VESSEL GRAFT; ELECTROSPINNING; HEART; HEMODIALYSIS; HUMAN; IN VIVO STUDY; PROSTHESIS; REVIEW; TISSUE ENGINEERING; XENOGRAFT;

EID: 80052979411     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.6451     Document Type: Review

References (52)

1. Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM. The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs 1960; 6: 114-22.
2. Debakey ME, Cooley DA, Morris GC Jr, Collins H. Arteriovenous fistula involving the abdominal aorta: report of four cases with successful repair. Ann Surg 1958; 147: 646-58.
3. Voorhees AB Jr, Jaretzki A 3rd, Blakemore AH. The use of tubes constructed from vinyon "N" cloth in bridging arterial defects. Ann Surg 1952; 135: 332-6.
4. Klinkert P, Post PN, Breslau PJ, van Bockel JH. Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature. Eur J Vasc Endovasc Surg 2004; 27: 357-62.
5. Hodges TC, Fillinger MF, Zwolak RM, Walsh DB, Bech F, Cronenwett JL. Longitudinal comparison of dialysis access methods: risk factors for failure. J Vasc Surg 1997; 26: 1009-19.
6. Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008; 299: 2164-71.
7. Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002; 62: 1109-24.
8. National Kidney Foundation. KIDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1-266.
9. Conte MS. The ideal small arterial substitute: a search for the Holy Grail? FASEB J 1998; 12: 43-5.
10. Kakisis JD, Liapis CD, Breuer C, Sumpio BE. Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg 2005; 41: 349-54.
11. Carrel A. La technique operatoire des anastomoses vasculaires et de la transplantation des visceres. Lyon Med 1902;98:805.
12. Friedman SG. A history of vascular surgery. 2nd ed. Malden, MA: Blackwell, 2005; 17-21.
13. Sparks CH. Autogenous grafts made to order. Ann Thorac Surg 1969; 8: 104-13.
14. Sparks CH. Silicone mandril method for growing reinforced autogenous femoro-popliteal artery grafts in situ. Ann Surg 1973; 177: 293-300.
15. Hallin RW, Sweetman WR. The Sparks' mandril graft: a seven year follow-up of mandril grafts placed by Charles H. Sparks and his associates. Am J Surg 1976; 132: 221-3.
16. Bowald S, Busch C, Eriksson I. Arterial regeneration following polyglactin 910 suture mesh grafting. Surgery 1979; 86: 722-9.
17. Zilla P, Fasol R, Deutsch M, et al. Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg 1987; 6: 535-41.
18. Zilla P, Bezuidenhout D, Human P. Prosthetic vascular grafts: wrong models, wrong questions and no healing. Biomaterials 2007; 28: 5009-27. [pub 2007 Aug 3].
19. Deutsch M, Meinhart J, Zilla P, et al. Long-term experience in autologous in vitro endothelialization of infrainguinal ePTFE grafts. J Vasc Surg 2009; 49: 352-62 [discussion: 362]. Epub 2008 Dec 25.
20. Weinberg C, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986; 231: 397-400.
21. Rosenberg N, Martinez A, Sawyer PN, et al. Tanned collagen arterial prosthesis of bovine carotid origin in man: preliminary studies of enzyme-treated heterografts. Ann Surg 1966; 164: 247-56.
22. Hutchin, P, Jacobs JR, Devin, JB, Shaughnessy S, Roland AS. Bovine graft arteriovenous fistulas for maintenance hemodialysis. Surg Gynecol Obstet 1975; 141: 255-8.
23. Kaplan MS, Mirahmadi KS, Winer RL, Gorman JT, Dabirvavziri N, Rosen SM. Comparison of "PTFE" and bovine grafts for blood access in the dialysis patients. Trans Am Soc Artif Intern Organs 1976; 22: 388-93.
24. Katzman H, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Prospective non-randomized multicenter evaluation of the mesenteric vein bioprosthetic graft for hemodialysis access in patients with prior failed prosthetic grafts. In: Henrly ML, ed. Vascular access for hemodialysis IX. Los Angeles, CA: Bonus Books, 2005; 169-83.
25. Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH. Multicenter evaluation of the bovine mesenteric vein bioprosthesis for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg 2005; 201: 223-30.
26. Darby CR, Ros D, Deardon D, et al. Depopulated bovine ureteric xenograft for complex hemodialysis vascular access. Eur J Vasc Surg 2006; 31: 181-6.
27. Matsurra JH, Rosenthal D, Wellons ED, et al. Hemodialysis graft infections treated with cryopreserved femoral vein. Caridovasc Surg 2002; 10: 561-5.
28. Bolten WD, Cull DL, Taylor SM, et al. The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg 2002; 36: 464-8.
29. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001; 344: 532-3.
30. Shin'oka T, Matsumura G, Hibino N, et al. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005; 129: 1330-8.
31. Soletti L, Hong Y, Guan J, et al. A bilayered elastomeric scaffold for tissue engineering of small diameter vascular grafts. Acta Biomater 2010; 6: 110-22. Epub 2009 Jun 18.
32. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK. Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate. J Biomed Mater Res 2000; 49: 489-97.
33. Weiler A, Helling HJ, Kirch U, Zirbes TK, Rehm KE. Foreign-body reaction and the course of osteolysis after polyglycolide implants for fracture fixation: experimental study in sheep. J Bone Joint Surg Br 1996; 78: 369-76.
34. Hirai J, Matsuda T. Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: tissue regeneration process. Cel I Transplant 1996; 5: 93-105.
35. Huynh TN, Tranquillo RT. Fusion of concentrically layered tubular tissue constructs increases burst strength. Ann Biomed Eng 2010; 38: 2226-36.
36. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999; 85: 1173-8.
37. Chue WL, Campbell GR, Caplice N, et al. Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg 2004; 39: 859-67.
38. Sakai O, Kanda K, Ishibashi-Ueda H, et al. Development of the wing-attached rod for acceleration of, Biotube" vascular grafts fabrication in vivo. J Biomed Mater Res B Appl Biomater 2007; 83: 240-7.
39. Poh M, Boyer M, Solan A, et al. Blood vessels engineered from human cells. Lancet 2005; 365: 2122-4.
40. Ketharnathan V, Christie BA. Glutaraldehyde-tanned ovine collagen conduits as vascular xenografts in dogs: a preliminary report. Arch Surg 1980; 115: 967-9.
41. Edwards GA, Roberts G. Development of an ovine collagen-based composite biosynthetic vascular prosthesis. Clin Mater 1992; 9: 211-23.
42. Enzler, MA, Rajmon, T, Lachat M et al. Long-term function of vascular access for hemodialysis. Clin Transplant 1996; 10: 511-5.
43. Palumbo R, Niscola P, Calbria S, et al. Long term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract 2009; 14: c76-80.
44. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA. A completely biological tissue-engineered human blood vessel. FASEB J 1998; 12: 47-56.
45. L'Heureux N, Dusserre N, Konig G, et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med 2006; 12: 361-5.
46. L'Heureux N, McAllister TN, de la Fuente LM. Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med 2007; 357: 1451-3.
47. McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-6.
48. McAllister TN, Maruszewski M, Garrido SA, et al. Author's reply: effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 374: 201.
49. Clinical and economic issues in vascular access for hemodialysis. Madison, WI: ABA Inc 2002; Vascular Access Vol 1, no. 1.
50. US Renal Data System. USRDS 2009 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2009.
51. Rosas SE, Joffe M, Burns JE, Knauss J, Brayman K, Feldman HI. Determinants of successful synthetic hemodialysis vascular access graft placement. J Vasc Surg 2003; 37: 1036-42.
52. McAllister TN, Dusserre N, Maruszewski M, L'Heureux N. Cell-based therapeutics from an economic perspective: primed for a commercial success or a research sinkhole? Regen Med 2008; 3: 925-37.